Fri, Nov 28, 2014, 7:25 AM EST - U.S. Markets open in 2 hrs 5 mins

Recent

% | $
Quotes you view appear here for quick access.

OncoGenex Pharmaceuticals, Inc. Message Board

  • beachbarbob beachbarbob Oct 5, 2012 9:18 AM Flag

    P2 427 Postate Data,,,,, When?

    Do we get data late Q4/12 or sometime in Q1/13? TIA

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • As I read slide 22 of their presentation at the Rodman & Renshaw conference a few weeks ago, which is on the website under Investors/Webcasts & Presentations, they expect to present those results in early 2013. The website also has an updated poster presentation on that trial that was apparently presented on September 28 at the European Society for Medical Oncology conference. The results on disease progression and PSA decline seem generally consistent with what was presented earlier.

      As stated in the "conclusions" section of the poster, they are starting a P2 trial of 427 with abiraterone. It's listed on clinicaltrials.gov as NCT01681433 but it's not yet recruiting. It's designed "to evaluate the anti-tumor effects of adding OGX-427 to continuing abiraterone acetate and prednisone treatment in men with metastatic castrate-resistant prostate cancer (MCRPC) who have prostate-specific antigen (PSA) progression" and will enroll 74 patients.

 
OGXI
2.11+0.02(+0.96%)Nov 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.